Konferenzschrift | Kongress
Therapeutic management of metastatic breast cancer
- Sprache
-
Englisch
- Umfang
-
88 S.
- Maße
-
24 cm
- Anmerkungen
-
graph. Darst.
Literaturangaben
- ISBN
-
9783110121827
3110121824
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Erschienen in
-
Consensus development in cancer therapy ; 1
- Schlagwort
-
Brustkrebs
Metastase
- Beteiligte Personen und Organisationen
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin, New York
- (wer)
-
de Gruyter
- (wann)
-
1989
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Konferenzschrift
Beteiligte
- Kaufmann, Manfred
- de Gruyter
Entstanden
- 1989
Ähnliche Objekte (12)
Therapeutic strategies in primary and metastatic liver cancer
Molecular mechanism of early metastatic breast cancer dissemination
Breast cancer: diagnostic imaging and therapeutic guidance
Iodine map radiomics in breast cancer: prediction of metastatic status
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer
Epithelial-mesenchymal transition phenotypes impact on metastases formation in metastatic breast cancer
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease — the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Overall survival in metastatic breast cancer patients : a single-centre analysis (2000 - 2005)
Therapeutic strategies in primary and metastatic liver cancer
Molecular mechanism of early metastatic breast cancer dissemination
Breast cancer: diagnostic imaging and therapeutic guidance
Iodine map radiomics in breast cancer: prediction of metastatic status
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer
Epithelial-mesenchymal transition phenotypes impact on metastases formation in metastatic breast cancer
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease — the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Overall survival in metastatic breast cancer patients : a single-centre analysis (2000 - 2005)
Therapeutic strategies in primary and metastatic liver cancer
Molecular mechanism of early metastatic breast cancer dissemination
Breast cancer: diagnostic imaging and therapeutic guidance
Iodine map radiomics in breast cancer: prediction of metastatic status
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer
Epithelial-mesenchymal transition phenotypes impact on metastases formation in metastatic breast cancer
Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease — the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients